BMS did, however, report a win for the quarter, with sales of its growth portfolio—which includes Opdivo and Cobenfy—increasing 16% year over year to $5.6 billion.

Those two ingredients have led analyst Matt Fontana to conclude which of the four quarterbacks should be considered the favorite to land the starter role in 2025. Fontana revealed who he’s convinced ...

Applications are now open. The deadline to apply is May 16 at 4:29 p.m. The Starter Company Plus Grant supports eligible entrepreneurs looking to build their small businesses. Select entrepreneurs ...

CLEVELAND, Ohio (WOIO)—A crash on I-90 East at about West 46th Street closed the highway in both directions Saturday morning. According to the Ohio Department of Transportation, all lanes on I ...

[Operator Instructions] As a reminder ... And finally, a standout achievement in 2024 was the FDA approval of COBENFY, which was invented at PureTech for the treatment of schizophrenia in adults ...

The Cleveland Browns now have four quarterbacks looking to be the starter. This isn’t necessarily an ideal scenario. With that in mind, Ken Carman and Anthony Lima asked NFL analyst Brian Baldinger ...

The company was recently stung by a string of clinical trial failures across several key pipeline assets, including cancer drug Opdualag, neuroscience drug Cobenfy, and heart medication Camzyos.

With Thunderbolts*, Marvel Studios adapts one of the longstanding Marvel Comics superteams, created in the 1990s, to discuss whether characters considered villains could genuinely reform. The core ...

But jump starters are there for the worst of times. When you need to drive your car, but the battery has drained flat, a jump starter can be a lifesaver. And if your battery hasn’t degraded enough, a ...